An Edinburgh based diabetic patient has been told she will be not given the new closed loop diabetic pump technology, despite the fact that she has been testing the system, for the NHS since last year.
Megan Ormond, who has had diabetes for all her teenage and adult life, contacted Labour MSP, Sarah Boyack to raise her situation.
Ms Ormond was taking part in a study of the closed loop system and was told partaking in this study would likely secure her the technology faster.
However, at her last meeting, she was told, due to budget cuts, the closed loop system would not be made available to her after the study.
While using this closed loop system, her HBA1C which is used by doctors to test a patient’s glucose levels over the last 3 months, has been the lowest it has been for her entire time with diabetes.
The Scottish Government’s Diabetic Improvement Plan cites rolling out the closed loop system, as quickly as possible as a key target.
However, due to budget cuts and required savings, NHS Lothian is unable to carry out their rollout of the system at their expected rate.
NHS England began rolling out the closed loop system on the 1st April 2024.
Commenting on Megan’s case, Lothians MSP Sarah Boyack, said: “Megan’s case shows the absolutely shocking state the SNP Government has allowed NHS Lothian to fall into.
“Life changing technology and treatment are being denied to patients due to a lack of funding. That is unacceptable anywhere in Scotland, never mind our nation’s capital.
“The Scottish Government must act to ensure Megan and other diabetics are able to access this ground-breaking treatment as they were promised.
“There is real opportunity to improve the quality of life for diabetes patients in Edinburgh, but that opportunity isn’t just being denied to my constituents its being snatched away.”
A closed loop system is a game changer for T1 diabetics. One of my constituents tested this system for the NHS However, due to budget cuts the system can’t be rolled out as planned and she must revert to her old insulin pump. The SNP's cuts are rolling back these opportunities pic.twitter.com/P7i40rNDc8
Holyrood agrees continuation of policy and increase to 65p
The minimum price per unit of alcohol will increase by 15 pence after the Scottish Parliament approved plans to continue with the public health measure.
As part of a ‘sunset clause’ when Minimum Unit Pricing (MUP) legislation was introduced in 2018, it had been due to end on 30 April, however today’s vote by MSPs ensures its continuation.
In addition, a price increase was required to counteract the effects of inflation, with a rise to 65p selected as the Scottish Government seeks to increase the positive effects of the policy.
The increase will take effect on 30 September 2024.
Drugs and Alcohol Policy Minister Christina McKelvie said: “I’m pleased that Parliament has agreed to continue MUP legislation and to raise the level it is set at.
“Research commended by internationally-renowned public health experts estimated that our world-leading policy has saved hundreds of lives, likely averted hundreds of alcohol-attributable hospital admissions and contributed to reducing health inequalities.
“Despite this progress, deaths caused specifically by alcohol rose last year – and my sympathy goes out to all those who have lost a loved one. However, as a letter to The Lancet by public health experts makes clear, it is likely that without MUP there would have been an even greater number of alcohol-specific deaths.
“As we have made clear, the policy aims to reduce alcohol-related harm by reducing consumption at population level, with a particular focus on targeting people who drink at hazardous and harmful levels.
“We believe the proposals strike a reasonable balance between public health benefits and any effects on the alcoholic drinks market and impact on consumers. Evidence suggests there has not been a significant impact on business and industry as a whole but we will continue to monitor this.”
MPs to vote on legislation to create first smoke-free generation, protecting young people turning 15 this year or younger from harms of smoking
MPs will vote today (16th April 2024) on world-leading legislation to protect future generations across the UK from the harmful effects of smoking.
The Tobacco and Vapes Bill would make it an offence to sell tobacco products to anyone born after 1 January 2009 – children aged 15 or younger today. Smoking itself would not be criminalised and anyone who can legally buy tobacco today will never be prevented from doing so in the future by the legislation.
If passed, the Bill will progress to the next stage, bringing the UK closer to creating the first smoke-free generation.
Responsible for around 80,000 deaths annually, smoking is the UK’s single biggest preventable killer and costs the NHS and economy an estimated £17 billion a year—far more than the £10 billion annual revenue from tobacco taxation.
It is also highly addictive – 4 in 5 smokers start before the age of 20 and remain addicted for the rest of their lives despite most smokers having tried to quit.
The legislation will cover all tobacco products, recognising that tobacco kills two-thirds of long-term users. In England alone, almost every minute someone with a smoking-related condition is admitted to hospital.
The Bill will help deliver the Prime Minister’s commitment of creating a smokefree generation which could prevent over 470,000 cases of heart disease, stroke, lung cancer and other deadly diseases by the turn of the century.
Alongside action to prevent creating future smokers, the government has already announced significant additional funding for stop smoking services over the next five years, effectively doubling the money available for local initiatives that can help existing smokers to quit. The government is also rolling out an innovative financial incentives scheme to help all pregnant smokers to quit.
Health and Social Care Secretary, Victoria Atkins, said: “Too many people know someone whose life has been tragically cut short or irreversibly changed because of smoking, which despite significant progress remains the UK’s biggest preventable killer.
“The truth is that there is no safe level of tobacco consumption. It is uniquely harmful and that is why we are taking this important action today to protect the next generation.
“This Bill will save thousands of lives, ease the strain on our NHS, and improve the UK’s productivity.”
The Tobacco and Vapes Bill would also give the government new powers to tackle youth vaping by restricting flavours and regulating the way that vapes are sold and packaged to make them less appealing to children.
While vaping can play a useful role in helping adult smokers to quit, non-smokers and children should never vape. The long-term health impacts of vaping are unknown and the nicotine contained within them can be highly addictive.
To ensure compliance with the new rules, trading standards officers will be given new powers to issue on-the-spot fines (fixed penalty notices) to retailers unlawfully selling tobacco or vapes to children. All the money raised would be used to fund further enforcement action.
The Bill follows the government’s previously stated commitment to ban the sale and supply of disposable vapes under existing environmental legislation, which have been a key factor behind the rise in youth vaping. The ban is planned to take effect from April 2025.
Public Health Minister, Andrea Leadsom, said: “Smoking is the number one preventable cause of disability, ill health and death in this country. Once it becomes a habit, its addictive nature means that it is extremely difficult to stop.
“Because the case against these harmful products is so strong, it’s not surprising that the majority of the British public—including those who smoke and those who sell tobacco—support plans to protect the next generation from the misery of smoking.
“Our plan will save lives, ease the strain on our NHS, and ensure a brighter future for our children.”
Professor Chris Whitty, Chief Medical Officer for England said: “Smoking kills and causes harm at all stages of life from stillbirths, asthma in children, stroke, cancer to heart attacks and dementia.
“This Bill, if passed, will have a substantial impact – preventing disease, disability and premature deaths long into the future.”
Deborah Arnott, Chief Executive of Action on Smoking and Health, said: “The Tobacco and Vapes Bill being voted on today is radical but, hard as it is now to believe, so were the smokefree laws when they were put before parliament. Parliamentarians can be reassured that the public they represent back the Bill.
“New research just published by ASH shows that the majority of tobacco retailers and the public, including smokers, support the legislation and the smokefree generation ambition it is designed to deliver. This historic legislation will consign smoking to the “ash heap of history.”
Dr Charmaine Griffiths, Chief Executive at the British Heart Foundation said: “Smoking continues to devastate the nation’s health, taking 15,000 UK lives every single year due to cardiovascular disease alone.
“Raising the age of sale for tobacco each year will be a game changer, meaning that future generations are protected from serious disease and death caused by smoking.
“Decisive action is needed to end this ongoing public health tragedy – we urge every MP to vote for this landmark legislation at the Bill’s Second Reading.”
Professor Steve Turner, Royal College for Paediatrics and Child Health President, said: “Without a doubt the introduction of the Tobacco and Vapes Bill will save lives.
“By stopping children and young people from becoming addicted to nicotine and tobacco we decrease their chances of developing preventable diseases later in life, and will protect children from the harms of nicotine addiction.
“As paediatricians, we strongly urge MPs to use the important responsibility they have and support this Bill to protect children’s and our nation’s current and future health.”
Dr Ian Walker, Executive Director of Policy at Cancer Research UK, said: “Today’s vote is a critical step towards the UK becoming a world leader in tobacco control. By voting in favour of the age of sale legislation, MPs will be putting us on the right side of history, and helping to create the first ever smokefree generation.
“Smoking is still the leading cause of cancer in the UK. Now is the time to take action, end cancers caused by smoking and save lives.”
ASH Scotland has responded to yesterday’s Scottish Government’s Ministerial Statement on Working Towards a Tobacco-free Scotland by 2034 and Tackling Youth Vaping.
Sheila Duffy, Chief Executive of ASH Scotland, said: “We warmly welcome the Scottish Government’s commitment to reducing the harms caused by tobacco which continues to be the biggest preventable killer of people in Scotland with more than 8,000 deaths each year.
“We are pleased that the Minister has listened to concerns expressed by ASH Scotland and has confirmed the Scottish Government is content that, if the UK Government’s Tobacco and Vapes Bill is passed at Westminster, no one buying addictive, health harming tobacco products under-age in Scotland will be criminalised.
“We do, however, want to see the Scottish Government taking rapid action in laying, at the earliest practicable opportunity, its proposed restrictions tightening the rules on the advertising and promotions of recreational vaping products which were consulted on two years ago in Spring 2022 and are enabled by legislation passed in Holyrood back in 2016.
“Following mounting evidence of adverse health impacts, and studies consistently showing that youngsters who use e-cigarettes are up to three times at greater risk of starting to smoke tobacco, government must move at pace to take all vital steps to protect young people’s health.
“Waiting for potential four-nation agreement by MPs at Westminster, with a General Election pending, presents a severe risk of delays to regulations that children’s health and wellbeing can ill afford.
“As most e-cigarettes contain high levels of nicotine, which is extremely addictive, as well as toxic chemicals that have not been safety tested for inhalation and can damage lung health, retail marketing restrictions need to be introduced urgently as a vital measure to discourage youth vaping by reducing the promotion and visibility of e-cigarettes on our high streets and in communities across Scotland.”
Smokers are being urged to make a quit attempt this No Smoking Day to improve their health and wealth
5.3 million smokers in England urged to make a quit attempt this No Smoking Day, as one of the best things they can do for their health and their wealth
With up to two in three long-term smokers dying from smoking and causing 64,000 deaths in England each year – No Smoking Day remains important 40 years on from its launch
It’s never too late to quit’: presenter Coleen Nolan tells us why she is stopping smoking following a recent health scare and reassures others on taking first steps to a smokefree life
It comes as the Prime Minister’s landmark legislation to create a smokefree generation is due to be introduced,
Leading charities, including ASH, Cancer Research UK and Asthma + Lung UK, are joining forces with the government to encourage the nation’s 5.3 million smokers to make a quit attempt this No Smoking Day, 13 March.
The campaign comes as part of the government’s bold plans to bring about the first smokefree generation and introduce legislation so children turning fifteen this year or younger can never legally be sold tobacco. Almost every minute of every day someone is admitted to hospital in England with a smoking-related disease and in 2022-23 there were over 400,000 hospital admissions in England due to smoking.
Quitting smoking is the best thing you can do for your health, at any age, and the benefits begin immediately. After eight hours your oxygen levels recover and the harmful carbon monoxide level in your blood will have reduced by half. After 48 hours all carbon monoxide will have flushed out, your lungs will clear out mucus and your sense of taste and smell improve.
Stopping smoking is also one of the best things people can do to save money to spend on other things. The average smoker spends around £47 a week on tobacco, which is around £2,450 a year. More broadly, it costs society over £17 billion per year, which includes a £14 billion cost to productivity and £3 billion cost to the NHS and social care.
UK Public Health Minister Andrea Leadsom said: ”Smoking is the biggest preventable killer in the UK and places a huge burden on our NHS. Cigarettes are responsible for 64,000 deaths a year in England – no other consumer product kills up to two-thirds of its users.
“That’s why No Smoking Day is still so important 40 years on from its launch. We are taking action to prevent our children from ever lighting a cigarette, and our proposed historic Tobacco and Vapes Bill will safeguard the next generation from the harms of smoking and risk of addiction.
Up to two in three long-term smokers will die from their smoking. Despite the harms associated with smoking, it’s estimated that nearly 50 million cigarettes are smoked every day in England, with every single one negatively impacting the smoker’s health.
Chief Medical Officer for England Professor Chris Whitty said: “Cigarettes kill. They cause at least 15 different types of cancers and increase your risk of developing more than 50 serious health conditions.
“Quitting smoking is one of the best things you can do for your health – no matter your age or how long you have smoked.”
Today, presenter, singer and TV personality Coleen Nolan – who smoked for over 40 years and is currently on her quitting journey following a health scare – shares her story to encourage others to join her.
Singer and presenter Coleen Nolan said: “I smoked for about 40 years and was heavily influenced by my friends and family around me. At such a young age I wasn’t aware of the health risks of smoking and soon found myself becoming addicted.
“Following a recent health scare, I realised how precious life is and became determined to quit, not just for my own health, but so I can be there fully for my children and grandchildren. To anyone out there thinking of giving up smoking, my advice is do it! ”
She is joined by ex-smoker and cancer survivor Sue Mountain who shares her story in a bid to urge smokers to quit smoking before it’s too late. Sue features in a powerful TV advert released by the department as part of a new Smokefree campaign, encouraging people to quit smoking.
Sue Mountain said: ”I never once thought I’d get cancer. Not once. To tell your family you’ve got cancer through smoking, is really hard. My kids thought they were going to lose their mam.”
Smoking rates have reduced by two-thirds since the first year of No Smoking Day 40 years ago, but smoking is still the single largest preventable cause of death in England – estimated to account for 64,000 deaths annually.
Stopping smoking is the best thing people can do for their health, and it can significantly reduce the risk of younger people taking up smoking and becoming addicted. Currently, four in five smokers start before the age of 20 and smoking from a younger age is linked to being more likely to smoke in later years.
Better Health offers a range of free quitting support, including a local stop smoking services look-up tool and advice on stop smoking aids, including information on how vaping can help you quit smoking.
As part of the government’s Swap to Stop scheme, almost one in five of all adult smokers in England will have access to a vape kit alongside behavioural support to help them quit the habit and improve health outcomes.
Plans to introduce the most significant public health intervention in a generation and phase out smoking are progressing at pace, with the UK now in the lead to be the first country in the world to create a smokefree generation. The UK government is proposing the phasing out of the sale of tobacco so that any child born on or after 1 January 2009 can never legally be sold cigarettes.
Be part of the change and help build a smokefree generation. For free support to quit this No Smoking Day, search ‘Smokefree’.
A health expert has issued a warning to people not to save unused antibiotics at home to take later at their own discretion – as this risks more harm than good.
As concerns over antibiotic resistant infections grow, an expert from Healthcare Improvement Scotland has urged people to avoid using antibiotics they may have saved up at home, as their overuse presents a serious threat to the future of healthcare.
Professor Andrew Seaton, Chair of the Scottish Antimicrobial Prescribing Group (SAPG), part of Healthcare Improvement Scotland, said: “We know that many people have antibiotics at home which they or another family member have been previously prescribed and there can be a temptation, when feeling unwell, to use them.
“However, it’s quite likely, at times when chest and throat infections are common, that infection will be caused by one of the many circulating viruses rather than by an infection that requires an antibiotic.
“Antibiotics will not speed up recovery from a viral illness and they may cause unwanted effects including stomach upset. Critically, future infections may be more difficult to treat because overuse of antibiotics drives the development of antibiotic resistance.”
Using antibiotics that have been lying around the house for a while means they may also have expired. Once the expiration date of a medicine has passed there’s no guarantee that it will be either safe or effective.
A survey of 2000 people in 2022 found that one in three people said they had taken expired medicines and almost a third of these said they had taken medicines that were not meant for them.
The most common reason for an antibiotic prescription is for respiratory tract infections eg infections of the throat, ear or chest.
Professor Seaton, an infectious diseases consultant in NHS Greater Glasgow and Clyde, explained: “Although we are making progress in getting across the importance of not overusing antibiotics, we know that the pandemic has had a significant impact on our healthcare system including the way in which people access healthcare advice.
“We think this has at least contributed to an increase in the use of antibiotics. Work is still needed to protect our population from the very real threat of antibiotic resistant infections and to help preserve our precious antibiotics for future generations as well as for those who need them most now.”
Professor Seaton has also highlighted the importance of safe disposal of unused medicines. He said: “Antibiotics don’t only act on germs inside of us, but also act on the many germs living in soil and water and we know that antibiotic resistance in the environment has important consequences for plant, animal and human health.
“It’s essential therefore that we avoid environmental contamination by not disposing of antibiotics in household waste for landfill or flush them down the toilet. Safe disposal of unused antibiotics will reduce the environmental impact and help protect our planet.”
Global analysis of more than 200 countries in 2019, before the COVID-19 pandemic, estimated that infections due to antibiotic resistance are now a leading cause of death worldwide, higher even than HIV/AIDS or malaria.
More than one million deaths are estimated to occur annually as a direct result of antibiotic resistant infections due to common, previously treatable infections such as pneumonia and bloodstream infections.
In a bid to encourage people to safely dispose of unused antibiotics, pharmacies throughout Scotland are offering an ‘amnesty’ where people can return medicines to them to be safely disposed of.
Professor Seaton said: “For the majority of people who are feeling unwell with a cough, cold or sore throat, symptoms will settle with simple measures including rest, increasing fluid intake and careful use of pain killers like paracetamol.“
There is a useful check list which people can go through on the NHS 24 website to decide if further advice is needed Cough | NHS 24 .
Professor Seaton added: “For people with known serious underlying health conditions or for those where symptoms are not settling within a few days or are worsening it is advisable to take advice from NHS 24, their pharmacist or GP.”
Report shows impact of Scotland’s first fast-track cancer diagnostic services
More than one in ten patients seen by new cancer diagnostic services have been referred for cancer treatment, helping to speed up treatment and improve outcomes. Patients waited an average of 14 days from referral, to having cancer ruled in or out.
An evaluation report into Scotland’s first Rapid Cancer Diagnostic Services (RCDS), published by the University of Strathclyde and the Centre for Sustainable Delivery (CfSD), found 11.9% of patients seen over the two year period were diagnosed with cancer. Around 6% were given a pre-cancer diagnosis, meaning they require further monitoring in case a cancer develops, and the remainder were either given the all clear and referred back to primary care or diagnosed with other non-cancer conditions (41.1% and 40.7% respectively).
The Rapid Cancer Diagnostic Services, currently in place across five Health Board areas, were established to help speed up cancer diagnoses for patients with non-specific symptoms such as unexplained weight loss, persistent nausea or fatigue, where the GP has a concern of a malignancy. Over the two-year evaluation period the services saw 2,489 patients, with more than 96% of them giving the service a positive satisfaction rating of eight out of 10 or more.
The report highlighted that the model delivers a quality service at speed, is cost effective, compared to previous pathways, and highly valued by patients and staff. Positive patient experience is attributed to the speed of referral, reduction in waiting times for diagnostic tests, having a single point of contact and enhanced information and communication throughout the RCDS pathway.
Visiting NHS Lanarkshire’s RCDS at University Hospital Wishaw, Health Secretary Neil Gray said: “Improving cancer services is a priority for the Scottish Government, as set out in our 10-year strategy published last year.
“This positive evaluation of Scotland’s Rapid Cancer Diagnostic Service provides valuable insight into their role in achieving vital earlier cancer diagnoses and improving patient care.
“RCDSs reflect our commitment to enhancing equitable cancer services across NHS Scotland – this report has shown the pivotal role they can play in early cancer detection while delivering quality patient-centred care. As Scotland’s cancer care continues to evolve, RCDSs stand as an essential component in improving outcomes.”
Professor Robert van der Meer, Co-Lead Author of the RCDS Evaluation, University of Strathclyde: “Scotland’s Rapid Cancer Diagnostic Services (RCDS) are working well. They’re achieving what they set out to do – find cancer – while delivering a high standard of quality care at speed.
“RCDS patients are complex and the specialist input that the RCDS can offer them, and concerned primary care clinicians, marks a gear-change in how we diagnose cancer in Scotland. RCDSs should be used as an exemplar for cancer care with learning embedded across all pathways.”
Mr Martin Downey, NHS Lanarkshire Rapid Cancer Diagnostic Service Clinical Lead and Associate Medical Director for Access, said: “The Rapid Cancer Diagnostic Service offers a timely, often one-stop, environment for clinically complex patients with potentially serious non-specific symptoms suspicious of cancer, such as weight loss, fatigue, nausea and abdominal pain.
“These patients typically did not meet the criteria for existing cancer pathways and the service makes a positive difference to these patients, providing rapid patient centred assessment, diagnosis and coordination of ongoing care.”
Labour Lothians MSP, Sarah Boyack, highlighted new research from Sight Scotland, which reveals that a quarter of all Scotland’s sight loss population, live within council areas served by Edinburgh’s Princess Alexandra Eye Pavilion.
Edinburgh’s Eye Pavilion was deemed not fit for purpose, by the NHS, in 2014 and has been the subject of a long running campaign to have it replaced.
In this time, waiting times have skyrocketed, with research from Sight Scotland highlighting that the number of ongoing waits has increased by over 10,000 since 2014.
With reports of appointments cancelled or delayed due to maintenance issues, it is likely this will only increase as the facility deteriorates further.
These numbers illustrate the extent of the crisis hitting eye care on the East coast of Scotland.
All this comes as the Scottish Government has backtracked on their election commitment to replace the current Eye Pavilion.
The Scottish Government’s recent budget froze capital spending for a minimum of two years, ensuring the new Eye Hospital could not go ahead and throwing its long-term future into doubt.
Sight Scotland have identified safety risks for both patients and staff due to the dilapidated state of the current facilities.
There is also a lack of clarity regarding what actions will be taken in the interim to ensure that the 45,000 people with sight loss, in the Pavilion’s remit, are able to receive the adequate care they require.
Commenting on the figures, Ms Boyack said: “We knew there was a crisis in eyecare, but now we know the full extent of it.
“The fact that a quarter of all those with sight loss are having to rely on not fit for purpose facilities is a national disgrace.
“And now the Scottish Government is subjecting them to unknown delays due to SNP budget cuts.
“Patients don’t just deserve a new hospital, they need one.
“If the Scottish Government does not act soon, there will be dire long-term consequences for Edinburgh’s sight loss population.”
Peter Scobbie, a long-time patient of the Eye Pavilion, added: “I’ve been going to the Princess Alexandra Eye Pavilion for 18 years now and the building is in shocking condition.
“The layout is completely inaccessible with the patient support services on the top floor and the pharmacy on the bottom next to the waiting area.
“Half the time the lifts are out of order, so I’m forced to use the stairs which I don’t feel safe doing as the handrail is very low and a straight drop down to the ground.
“I’d go as far to say it’s dangerous, especially for people with no to low sight.
“The decision not to fund a new hospital is therefore incredibly disappointing and I’m worried for other patients and the growing number of people who will need specialist eye care soon – what will they do?”
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Countless lives could be saved thanks to a multi-million pound UK government investment in potential breakthrough medical devices.
As part of a £10 million funding package for boosting access to medical technology, eight innovative tech companies will be supported to bring their devices to market. It could help transform the way we treat some of the biggest causes of death and disability in the UK.
One device, by HistoSonics, aims to identify and destroy liver cancer tumours using focused ultrasound waves. These waves break down tumours without damaging healthy tissue, offering a safer alternative to radiotherapy and other high intensity treatments. It could improve quality of life for many patients going through treatment – reducing hospital visits, post procedure complications, and making pain management easier.
Today’s announcement is part of the government’s long-term plan to ensure the NHS and its patients can get quicker access to new ‘groundbreaking’ technologies. It follows the unveiling of our groundbreaking blueprint for boosting NHS medtech and turning innovation into real benefits for society last year.
Health Minister Andrew Stephenson said: “NHS staff need access to the latest technology to deliver the highest quality care for patients and cut waiting lists – one of our top five priorities.
“These cutting-edge technologies could help thousands of patients with a range of conditions, including cancer, stroke, and Alzheimer’s, while easing pressure on our hospitals and reducing healthcare inequalities.
“Our investment in these pioneering companies is part of our long-term plan for a faster, simpler and fairer health care system, and demonstrates our clear commitment to ensuring the UK is the most innovative economy in the world.”
One company is developing a blood test for Alzheimer’s Disease which means patients could be identified and treated earlier. Roche Diagnostics Ltd has developed the Amyloid Plasma Panel – a blood test which could help clinicians decide if patients with cognitive impairment should undergo tests or imaging to confirm Alzheimer’s Disease.
A portable blood test, from Upfront Diagnostics, could help paramedics identify stroke patients more quickly. Currently, ambulance workers can’t recognise a patient with a blood clot blocking the flow of blood and oxygen to their brain, who would require urgent treatment at stroke centres rather than local hospitals.
The blood test could help them recognise these cases on the spot – so patients could be taken to a comprehensive stroke centre for immediate, vital treatment. It could mean thousands are spared long-term disability and the associated care costs, while reducing pressure on A&E departments nationwide.
Dr Marc Bailey, Medicines and Healthcare products Regulatory Agency Chief Science and Innovation Officer, said: “We are very excited to announce the final eight selected technologies in the new IDAP pilot scheme.
“This is designed to explore how support from the regulator, UK health technology organisations and NHS bodies can accelerate the development of transformative medical devices from their initial proof of concept through to uptake in the NHS.
“The pilot criteria prioritises patient need in all aspects of decision-making and, by supporting innovative medical technologies, will ease pressure on the healthcare system. Most important, it’s an initiative which could be life-changing for many patients.
“We are committed to being a regulator that establishes the UK as a centre of medical innovation and look forward to working with the wider healthcare system to achieve this.”
The funding is part of a radical new programme called The Innovative Devices Access Pathway (IDAP), which aims to bring state-of-the-art technologies and solutions to the forefront of the NHS. Currently in the pilot stage, the funding will be used to test the new technologies for use on a large scale as quickly as possible.
The government is investing £10 million in the pilot as part of a wider programme of work to accelerate access to medical technology.
The programme is run by the Medicines and Healthcare products Regulatory Agency (MHRA), The National Institute for Health and Care Excellence (NICE), NHS England, Health Technology Wales, and Scottish Health Technology Group. They will be providing tailored, intensive advice on regulatory approval, health tech assessments and access to the NHS.
Jeanette Kusel, Director of NICE Advice (The National Institute for Health and Care Excellence) said: “NICE’s ambition is to drive innovation into the hands of health and care professionals to enable best practice in health and care treatment.
“Through IDAP and our support service NICE Advice, we aim to be a trusted adviser, providing tailored advice and supporting businesses along the whole product lifecycle helping them realise their ambition and helping bring the very best of innovation into the NHS and the hands of patients.”
Lenus Health Ltd. is using artificial intelligence to predict patients at risk of hospitalisation for Chronic Obstructive Pulmonary Disease, which causes the airways to become narrow and damaged, resulting in breathing difficulties.
The company collects data from wearable devices, sensors and apps and uses AI to predict which patients are at greater risk of hospital admissions. This allows them to be monitored and treated more effectively, while simultaneously reducing pressure on hospitals.
Another device aims to reduce inequalities in the field of lung health. Oximeters – devices clipped over the end of a fingertip – are used widely at hospitals and at home to assess how well the lungs and circulatory system are working. However, research suggests this technology may not accurately detect falling oxygen levels in people with darker skin tones.
EarSwitch has produced a device which detects oxygen levels from the inner ear-canal instead, which is not pigmented irrespective of the person’s skin colour. It could offer better quality readings and a more innovative approach to oxygen level monitoring.
Vin Diwakar, Interim National Director of Transformation, NHS England, said: “This is an important milestone in our work to ensure the NHS continues to get the best new technologies and treatments to patients faster, having already rolled out more than 100 new treatments through the cancer drug fund and setting up a dedicated programme to prepare for new Alzheimer’s treatments once they are approved.
“We will be working closely with our partners to support those companies selected for the pilot so that more game-changing, life-saving technologies are introduced quickly and safely on the NHS.”
Other technologies set to benefit from a share of the funding include:
Multiple Sclerosis fatigue app: Avegen Ltd. has developed a new smartphone app that delivers exercises, cognitive behaviour therapy and targeted physical activity in a personally customisable format to help patients manage Multiple Sclerosis (MS).
Self-test for neutropenia: 52 North Health. has developed a new device to allow chemotherapy patients to self-test at home – using a finger-prick blood test – for neutropenic sepsis. This is a life-threatening condition in patients whose immune system is suppressed.
Algorithm infection predictor: Systemic Inflammatory Response Syndrome (SIRS) is a life-threatening medical condition caused by the body’s overwhelming response to infection or inflammation. Presymptom Health Ltd. has developed a new test and algorithm with the potential to predict infection status up to three days before conventional diagnosis is possible.
Dr Susan Myles, Director of Health Technology Wales, said: “Health Technology Wales is proud to have played a role in the selection of eight pilot IDAP technologies which have the potential to support clinicians and improve the lives of patients across the UK.
“We look forward to continuing to support the adoption of innovative health technologies by the NHS.”
A proposal for air quality monitors to be trialled in Aberdeen, Dundee, Edinburgh, Glasgow and Perth
Doctors encourage Scottish Government to take forward schools air quality monitor pilot
A proposal for air quality monitors to be trialled in Aberdeen, Dundee, Edinburgh, Glasgow and Perth
The Royal College of Physicians of Edinburgh (“the College”) is urging the Scottish Government to take forward its proposal to monitor air quality around urban schools in Scotland.
The College’s costed pilot proposal would see air quality monitors placed for a year in up to three schools, within 50m of those schools, in each of five Scottish cities: Aberdeen, Dundee, Edinburgh, Glasgow and Perth. The pilot would therefore see up to 15 schools across Scottish cities taking part.
Last year, the College called for air quality monitors to be placed at all city primary schools in Scotland for a period of at least a year, in its submission of evidence to the Scottish Parliament’s Net Zero, Energy and Transport Committee.
The pilot idea was developed by the College’s Working Group on Air Pollution and Health. It has now been submitted to the Scottish Government following positive discussions with government officials last year. Members of the Working Group highlighted the lack of data on air quality around schools despite the knowledge that air pollution can pose serious health risks to children.
As part of the working group’s preparation of the pilot proposal, clinicians plotted the distances between primary and secondary schools in these five city areas and existing air quality monitors.
The group found that from the 337 primary and 94 secondary schools examined, only one primary school was within 50m of a PM (particulate matter) monitor and only 2 primary schools were within 100m of a NO2 (nitrogen dioxide) monitor.
There were no secondary schools within 100m of either type of monitor.
Professor Jill Belch, Co-lead of the College’s Working Group on Air Pollution and Health, and Professor of Vascular Medicine at the University of Dundee, said:“Science has provided robust evidence that children are significantly harmed by air pollution, with sometimes tragic results.
“Whilst lung disease in children is widely recognised as a result of breathing polluted air, less well known to the public, but equally important, are the effects of this pollution on the developing organs within a child.
“For example, exposure to polluted air in childhood has been shown to reduce brain cognitive function in a number of key ways. Further, and of concern, is that children appear to become unwell at lower levels of pollutants than do adults.
“ At present the early work conducted by the Royal College of Physicians of Edinburgh suggests that few school have air quality monitors nearby, so we do not actually know how well or otherwise, our children are protected. It is therefore imperative that we ensure air quality around schools is within regulatory levels, and the College’s proposal to the Scottish Government can start this process.”
Professor Andrew Elder, President of the Royal College of Physicians of Edinburgh and the other Co-Lead of the Working Group on Air Pollution and Health, said:“ There is overwhelming evidence that air pollution can have a wide range of detrimental health impacts on our children including problems with the lung, heart, brain and immune and hormonal systems.
“We also know that there is a correlation between areas of high deprivation and poor air quality and this can exacerbate pre-existing health inequalities in children and young people.
“ We are concerned at the lack of data on air quality around urban schools in Scotland- with the vast majority of urban air quality monitors currently sited too far away from schools- and believe we must collect as much accurate school level data as possible so we can have an evidence base for action.
“The College hopes that the Scottish Government will consider our proposal positively and we remain committed to working constructively with it and all other stakeholders so that we can better understand the levels of air pollution around our schools and subsequently support implementing mitigation measures where these are required.”
Mike Corbett, National Official (Scotland) for the NASUWT said: “Thousands of people die each year because of occupational diseases caused by air pollution at work. Pollution arising from work and travel to work are health issues for which employers currently take little responsibility.
“Air pollution impacts workers and their families at all stages from before birth to old age and is particularly damaging to the growth and development of babies and children.
“ Being able to quantify the scale of the problem around our schools is the first step to cleaning up the air we and our children breathe and moving towards a heathier and safer future. NASUWT is therefore very pleased to endorse and support this proposal for pilot air quality monitoring around schools.”
